AI assistant
CONTROL BIONICS LIMITED — Board/Management Information 2021
Feb 7, 2021
64611_rns_2021-02-07_37b4c76b-d83f-4ee4-a7f7-25fe6f3660a0.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [102 x 36] intentionally omitted <==
8 February 2021
ASX ANNOUNCEMENT
Appointment of CFO
Control Bionics Limited (ASX: CBL) announces the appointment of Neale Java as Chief Financial Officer (CFO).
The appointment of Neale is part of a planned transition whereby CBL’s current CFO, John Bell, will remain with the company up to 1 April 2021 and will be responsible for completion of the half year accounts ended 31 December 2020. Neale will assume full CFO responsibilities from 1 March 2021. He will also have operational responsibilities for Australia and USA markets.
The Board of CBL would like to thank John for his exceptional work in assisting the company through the recent IPO process.
Neale brings extensive experience in driving the growth and profitability agendas of businesses and spearheading corporate development. This experience has been shaped over the past 15 years in fast-paced, high growth environments at established firms and disruptive ventures.
Neale holds a Bachelor of Electrical Engineering (BE) from University of Wollongong, Master of Applied Finance (MAppFin) from Macquarie University and Executive Master of Business Administration (EMBA) from INSEAD. He has also completed the Executive Program for Growing Companies (EPGC) at Stanford and is a Member of the Australian Institute of Company Directors (MAICD).
This announcement was authorised by the CEO, Rob Wong.
Investors
Brett Crowley - Company Secretary [email protected]
Business/Client Inquiries Rob Wong - CEO [email protected]
Media
M&C Partners Melissa Hamilton [email protected]
For further information visit the website: https://www.controlbionics.com/
Control Bionics Limited Registered Office: Suite G.03, 171 Union Road, Surrey Hills, VIC, 3127 T: +61 3 9897 3576 W: www.controlbionics.com
ABN: 45 115 465 462
About Control Bionics:
Control Bionics is a technology company which enables a disabled person to use their own neuroelectric signals, from their brain to a muscle, to control communication and movement through smartphones, tablets, computers and robotics, even when that muscle is not fully functional. The Company’s wireless wearable device, ‘ NeuroNode ’, is a world leader in electromyography (EMG), capturing and processing those neuroelectric signals into electronic commands to do everything they would normally do with a keyboard, mouse, joystick or touchscreen. The technology also enables a person to use their eyes to replace a mouse in controlling a cursor on a screen simply by looking where they want to cursor to move; and then to select anything under the cursor, using NeuroNode; providing fast, intuitive communication and control through text, text-to-speech, emails, phone-messaging, web surfing and robotics.
Control Bionics Limited Registered Office: Suite G.03, 171 Union Road, Surrey Hills, VIC, 3127 T: +61 3 9897 3576 W: www.controlbionics.com
ABN: 45 115 465 462